Yahoo Malaysia Web Search

Sign In

Search results

  1. www.modernatx.comPioneering mRNA technology - Moderna

    Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

  2. en.wikipedia.org › wiki › ModernaModerna - Wikipedia

    Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

  3. www.modernatx.com › about-us › our-storyOur Story - Moderna

    We’re making biotech history. Messenger RNA is not new technology, but we are discovering new ways to use it to treat and prevent illnesses and diseases. Since our founding in 2010, we have worked to build the industry's leading mRNA technology platform.

  4. www.modernatx.com › en-SGPioneering mRNA technology - Moderna

    Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. Learn more about us. Join us and change the world of medicine. Life at Moderna. So, what is mRNA? Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do.

  5. www.linkedin.com › company › modernatxModerna - LinkedIn

    About us. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all...

  6. news.modernatx.com › news › news-detailsModerna Receives U.S. FDA Approval for Updated COVID-19 Vaccine

    Sep 11, 2023 · Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine. September 11, 2023. Download. Clinical data show robust immune responses across multiple circulating variants, including EG.5, FL.1.5.1, and BA.2.86. Updated vaccine to be available in pharmacies and care settings across the U.S. in the coming days.

  7. news.modernatx.com › news › news-detailsModerna Achieves Positive Interim Results from Phase 3 Trial of...

    Mar 26, 2024 · mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222. Next-generation mRNA vaccine design offers the potential of longer shelf life and storage advantages, and paves the way for combination vaccine against influenza and COVID-19, mRNA-1083.